Literature DB >> 10948142

Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases.

G H Foster1, C S Armstrong, R Sakiri, V L Tesh.   

Abstract

Infections with Shiga toxin (Stx)-producing bacteria cause bloody diarrhea which may progress to life-threatening complications, including acute renal failure and neurological abnormalities. The precise mechanism of disease progression is unclear, although evidence suggests that the localized production of the host proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-1 may exacerbate toxin-mediated vascular damage. Purified Stxs have been demonstrated to elicit proinflammatory cytokine synthesis from human peripheral blood mononuclear cells and monocytic cell lines in vitro. To understand toxin-monocyte interactions required for cytokine synthesis, we have treated differentiated THP-1 cells with purified wild-type toxins, enzymatic mutants, or B subunits and measured TNF-alpha production. Our data suggest that A subunit enzymatic activity is essential for cytokine production. THP-1 cells were treated with a series of protein kinase C (PKC), PKA, and protein tyrosine kinase inhibitors to examine the role of intracellular signaling molecules in Stx-mediated cytokine production. Treatment of cells with PKC and tyrosine kinase inhibitors blocked TNF-alpha secretion by Stx-stimulated THP-1 cells. Stx treatment directly activated PKC, which occurred at a point upstream of transcriptional activation of the gene encoding TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948142      PMCID: PMC101776          DOI: 10.1128/IAI.68.9.5183-5189.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.

Authors:  S K Saxena; A D O'Brien; E J Ackerman
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

4.  Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Authors:  C M Thorpe; B P Hurley; L L Lincicome; M S Jacewicz; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Authors:  T G Obrig; P J Del Vecchio; J E Brown; T P Moran; B M Rowland; T K Judge; S W Rothman
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

7.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

8.  Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes.

Authors:  T Reimann; D Büscher; R A Hipskind; S Krautwald; M L Lohmann-Matthes; M Baccarini
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.

Authors:  M Jacewicz; H Clausen; E Nudelman; A Donohue-Rolfe; G T Keusch
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  24 in total

1.  Shiga toxin regulates its entry in a Syk-dependent manner.

Authors:  Silje Ugland Lauvrak; Sébastien Wälchli; Tore-Geir Iversen; Hege Holte Slagsvold; Maria Lyngaas Torgersen; Bjørn Spilsberg; Kirsten Sandvig
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

2.  Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1.

Authors:  Dinorah Leyva-Illades; Rama P Cherla; Cristi L Galindo; Ashok K Chopra; Vernon L Tesh
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

3.  Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells.

Authors:  Dinorah Leyva-Illades; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

4.  Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.

Authors:  Marina Morigi; Simona Buelli; Cristina Zanchi; Lorena Longaretti; Daniela Macconi; Ariela Benigni; Daniela Moioli; Giuseppe Remuzzi; Carla Zoja
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 5.  Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Authors:  Moo-Seung Lee; Myung Hee Kim; Vernon L Tesh
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

6.  Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.

Authors:  Zuhal Ergonul; Frederic Clayton; Agnes B Fogo; Donald E Kohan
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

7.  Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.

Authors:  Lisa M Harrison; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 8.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

9.  Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.

Authors:  Kristin A D Sauter; Angela R Melton-Celsa; Kay Larkin; Megan L Troxell; Alison D O'Brien; Bruce E Magun
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

10.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.